Novavax spikes 67% after UK study shows its COVID-19 vaccine is 89% effective (NVAX)

6:00am PST - January 29th, 2021    novavax stock - Business Insider

Summary List Placement

• Novavax soared 67% on Friday after a UK study on its COVID-19 vaccine demonstrated 89% efficacy in preventing the virus.
• The vaccine demonstrated clinical efficacy against the UK and South Africa variant strains.
<…